Glioblastoma in elderly patients: solid conclusions built on shifting sand?

Area of Science:

• Neuro-oncology
• Geriatric medicine
• Molecular oncology

Background:

• Glioblastoma management in elderly patients (over 65) presents unique challenges.
• This demographic is projected to constitute over half of glioblastoma cases soon.
• Limited clinical trial data historically impacted treatment intensity for older adults.

Purpose of the Study:

• To review the concept of the elderly patient population in glioblastoma research.
• To explore potential molecular distinctions in glioblastoma between elderly and younger patients.
• To evaluate recent clinical trials and discuss optimal therapeutic strategies for elderly glioblastoma patients.

Main Methods:

• Literature review focusing on glioblastoma in elderly populations.
• Analysis of evidence regarding molecular differences in glioblastoma based on age.
• Evaluation of recent first-line clinical trials for elderly patients.
• Discussion of current best practices and the role of molecular diagnostics.

Main Results:

• Recent clinical trials are beginning to provide more robust data for elderly glioblastoma patients.
• Molecular testing may reveal age-related differences influencing treatment response.
• Evidence suggests a need to re-evaluate historical treatment reluctance in this age group.

Conclusions:

• Effective glioblastoma management in the elderly requires tailored approaches.
• Molecular profiling is increasingly important for personalized treatment strategies.
• Future research should prioritize inclusion of elderly patients in clinical trials.